Results 91 to 100 of about 489 (130)

Cardiac myosin inhibitors for hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Hasana U, Korpal M, Haider F, Umer M, Lwin NPT, Iqbal S, Kumar R, Ahsan M, Hassan E, Ullah W, Khalid S, Gupta A, Alsubari AMA, Ehsan M, Ahmad A.   +14 more
europepmc   +1 more source

Cardiac myosin inhibitors: a silver lining for an old disease. [PDF]

Open Heart
Yadav S, Agstam S, Singh S.
europepmc   +1 more source

Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis. [PDF]

Eur Heart J Cardiovasc Pharmacother
Awad K, Pereyra Pietri M, Farina JM, Pathangey G, Abbas MT, Scalia IG, Le Couteur D, Wilanksy S, Lester SJ, Ommen SR, Geske JB, Arsanjani R, Ayoub C.   +12 more
europepmc   +1 more source

The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review. [PDF]

Heart Fail Rev
Othman L, Koskina L, Huerta N, Rao SJ.
europepmc   +1 more source

Hypertrophic Cardiomyopathy and Phenocopies: New Therapies for Old Diseases-Current Evidence and Future Perspectives. [PDF]

J Clin Med
Alfarano M, Ciccarelli F, Marchionni G, Ballatore F, Costantino J, Lattanzio A, Pecci G, Stavagna S, Iannelli L, Galardo G, Lavalle C, Miraldi F, Vizza CD, Chimenti C.   +13 more
europepmc   +1 more source

Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM [PDF]

Barriales-Villa, Roberto, Choudhury, Lubna, Cooper, Robert M, Elliott, Perry M, FOREST-HCM Investigators, Garcia-Pavia, Pablo, Hegde, Sheila M, Heitner, Stephen B, Jacoby, Daniel L, Kramer, Christopher M, Kupfer, Stuart, Malik, Fady I, Maron, Martin S, Masri, Ahmad, Melloni, Chiara, Nassif, Michael E, Oreziak, Artur, Owens, Anjali T, Saberi, Sara, Sherrid, Mark V, Simkins, Tyrell, Solomon, Scott D, Tower-Rader, Albree, Wai, Jenny   +23 more
core  

Coexistence of Hypertrophic Cardiomyopathy and Arterial Hypertension: Current Insights and Future Directions. [PDF]

Diseases
Katsi V, Papadomarkaki K, Manousiadis K, Triantafyllou E, Fragoulis C, Tsioufis K.   +5 more
europepmc   +1 more source

Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy. [PDF]

J Am Heart Assoc
Dybro AM, Rasmussen TB, Nielsen RR, Ladefoged BT, Pedersen ALD, Terkelsen CJ, Andersen MJ, Jensen MK, Poulsen SH.   +8 more
europepmc   +1 more source